Quant Healthcare Fund Regular vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Quant Healthcare Fund Regular - Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8352 Cr | ₹402 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹1000 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 17 Jun 2023 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare TRI |
Turn Over | 21% | % |
Expense Ratio | 1.82 | 2.39 |
Manager | Sailesh Raj Bhan | Sanjeev Sharma |
ISIN Code | INF204K01968 | INF966L01CG3 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Quant Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
---|---|---|
1 Month | 0.21% | -0.87% |
6 Month | 0.8% | 1.17% |
1 Year | 11.79% | 0.02% |
3 Year | 24.39% | - |
5 Year | 21.92% | - |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
---|---|---|
6 Month | 8.27% | 10.74% |
1 Year | 9.8% | 6.43% |
3 Year | 24.53% | - |
5 Year | 19.95% | - |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
---|---|---|
1 Year | 17.67% | 32.72% |
3 Year | 20.32% | - |
5 Year | 20.52% | - |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
---|---|---|
Standard Deviation | 14.75% | - |
Sharp | 1.20% | - |
Beta | 0.90% | - |
Alpha | 0.72% | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
---|---|---|
Name | Sailesh Raj Bhan | Sanjeev Sharma |
Total AUM | ₹96086 Cr | ₹39731 Cr |
Funds Managed | 5 | 22 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Quant Healthcare Fund Regular - Growth |
---|---|---|
Others | 1.42 | 16.87 |
Large Cap | 36.54 | 18.8 |
Mid Cap | 31.26 | 8.66 |
Small Cap | 30.78 | 55.67 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Quant Healthcare Fund Regular - Growth |
---|---|---|
Others | 1.42 | 16.37 |
Healthcare | 98.58 | 66.81 |
Energy | - | 0 |
Technology | - | 5.02 |
Consumer Defensive | - | 6 |
Financial Services | - | 5.81 |
Top Comparisons
Kotak Arbitrage Fund - Growth
3Y Returns7.12%
Aditya Birla Sun Life Arbitrage Fund - Regular Plan - Growth
3Y Returns6.87%
ITI Arbitrage Fund Regular - Growth
3Y Returns6.23%
UTI Arbitrage Fund - Regular Plan - Growth Option
3Y Returns6.95%
ICICI Prudential Credit Risk Fund - Growth
3Y Returns8.08%
UTI Credit Risk Fund - Regular Plan - Growth Option
3Y Returns7.39%
UTI Arbitrage Fund - Regular Plan - Growth Option
3Y Returns6.95%
Axis Arbitrage Fund - Regular Plan - Growth
3Y Returns6.76%